References
- Yamasaki K, Kanbe T, Chijiwa T, Ishiyama H, Morita S. (1987). Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat. Eur J Pharmacol, 142:23–29.
- Miyake M, Kamada N, Oka Y, Mukai T, Minami T, Toguchi H et al. (2004). Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine. J Control Release, 99:63–71.
- Miyake M, Minami T, Hirota M, Toguchi H, Odomi M, Ogawara K et al. (2006). Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: utilization of polyamines and bile acids. J Control Release, 111:27–34.
- Shin BS, Kim CH, Jun YS, Yoon CH, Rho JI, Lee KC et al. (2004). Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in rats. Drug Dev Ind Pharm, 30:869–876.
- Chiou WL, Riegelman S. (1971). Pharmaceutical applications of solid dispersion systems. J Pharm Sci, 60:1281–1302.
- Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
- Vasconcelos T, Sarmento B, Costa P. (2007). Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today, 12:1068–1075.
- Broadhead J, Edmond Rouan S, et al. (1992). The spray drying of pharmaceuticals. Drug Development and Industrial Pharmacy, 18:1169–1206.
- Yamasaki K, Ishiyama H, Imaizumi T, Kanbe T, Yabuuchi Y. (1989). Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats. Jpn J Pharmacol, 49:441–448.
- Son D, Thuong N, et al. (2005). High Performance Liquid chromatographic analysis of rebamipide in human plasma. Analytical letters, 38:997–1005.
- Arias M, Gines J, et al. (1995). Influence of the preparation method of solid dispersions on their dissolution rate: Study of triamterene-mannitol system. International journal of pharmaceutics,123:25–31.
- Jung JY, Yoo SD, Lee SH, Kim KH, Yoon DS, Lee KH. (1999). Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int J Pharm, 187:209–218.
- Ambike AA, Mahadik KR, Paradkar A. (2005). Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitroand in vivoevaluations. Pharm Res, 22:990–998.
- Taylor LS, Zografi G. (1997). Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res, 14:1691–1698.
- Matsumoto T, Zografi G. (1999). Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res, 16:1722–1728.
- Wang X, Michoel A, Van den Mooter G. (2005). Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int J Pharm, 303:54–61.
- Janssens S, Nagels S, Armas HN, D’Autry W, Van Schepdael A, Van den Mooter G. (2008). Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. Eur J Pharm Biopharm, 69:158–166.
- Ali W, Williams AC, Rawlinson CF. (2010). Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions. Int J Pharm, 391:162–168.
- Mura P, Cirri M, Faucci MT, Ginès-Dorado JM, Bettinetti GP. (2002). Investigation of the effects of grinding and co-grinding on physicochemical properties of glisentide. J Pharm Biomed Anal, 30:227–237.
- Vogt M, Vertzoni M, Kunath K, Reppas C, Dressman JB. (2008). Cogrinding enhances the oral bioavailability of EMD 57033, a poorly water soluble drug, in dogs. Eur J Pharm Biopharm, 68:338–345.
- Balani PN, Wong SY, Ng WK, Widjaja E, Tan RB, Chan SY. (2010). Influence of polymer content on stabilizing milled amorphous salbutamol sulphate. Int J Pharm, 391:125–136.
- Craig DQ. (2002). The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm, 231:131–144.
- Karekar P, Vyas V, Shah M, Sancheti P, Pore Y. (2009). Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188. Pharm Dev Technol, 14:373–379.
- Akamatsu T, Nakamura N, Furuya N, Shimizu T, Gotou A, Kiyosawa K et al. (2002). Local gastric and serum concentrations of rebamipide following oral ingestion in healthy volunteers. Dig Dis Sci, 47:1399–1404.